146 related articles for article (PubMed ID: 37288821)
21. Interferon-β alleviates delayed tPA-induced adverse effects via modulation of MMP3/9 production in ischemic stroke.
Kuo PC; Weng WT; Scofield BA; Furnas D; Paraiso HC; Intriago AJ; Bosi KD; Yu IC; Yen JH
Blood Adv; 2020 Sep; 4(18):4366-4381. PubMed ID: 32926126
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 mediates tissue plasminogen activator-induced MMP-9 up-regulation in cultured brain microvascular endothelial cells.
Jin X; Sun Y; Xu J; Liu W
J Neurochem; 2015 Mar; 132(6):724-30. PubMed ID: 25683686
[TBL] [Abstract][Full Text] [Related]
23. Interferon-β modulates microglial polarization to ameliorate delayed tPA-exacerbated brain injury in ischemic stroke.
Kuo PC; Weng WT; Scofield BA; Paraiso HC; Bojrab P; Kimes B; Yu II; Yen JJ
Front Immunol; 2023; 14():1148069. PubMed ID: 37063896
[TBL] [Abstract][Full Text] [Related]
24. tPA in the central nervous system: relations between tPA and cell surface LRPs.
Ortolano S; Spuch C
Recent Pat Endocr Metab Immune Drug Discov; 2013 Jan; 7(1):65-76. PubMed ID: 23231415
[TBL] [Abstract][Full Text] [Related]
25. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
26. Phthalide derivative CD21 attenuates tissue plasminogen activator-induced hemorrhagic transformation in ischemic stroke by enhancing macrophage scavenger receptor 1-mediated DAMP (peroxiredoxin 1) clearance.
Liu DL; Hong Z; Li JY; Yang YX; Chen C; Du JR
J Neuroinflammation; 2021 Jun; 18(1):143. PubMed ID: 34162400
[TBL] [Abstract][Full Text] [Related]
27. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
Wang X; Lee SR; Arai K; Lee SR; Tsuji K; Rebeck GW; Lo EH
Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
[TBL] [Abstract][Full Text] [Related]
28. Progesterone attenuates hemorrhagic transformation after delayed tPA treatment in an experimental model of stroke in rats: involvement of the VEGF-MMP pathway.
Won S; Lee JH; Wali B; Stein DG; Sayeed I
J Cereb Blood Flow Metab; 2014 Jan; 34(1):72-80. PubMed ID: 24045404
[TBL] [Abstract][Full Text] [Related]
29. Molecular insights and therapeutic targets for blood-brain barrier disruption in ischemic stroke: critical role of matrix metalloproteinases and tissue-type plasminogen activator.
Jin R; Yang G; Li G
Neurobiol Dis; 2010 Jun; 38(3):376-85. PubMed ID: 20302940
[TBL] [Abstract][Full Text] [Related]
30. Annexin A2 Plus Low-Dose Tissue Plasminogen Activator Combination Attenuates Cerebrovascular Dysfunction After Focal Embolic Stroke of Rats.
Fan X; Jiang Y; Yu Z; Liu Q; Guo S; Sun X; van Leyen K; Ning M; Gao X; Lo EH; Wang X
Transl Stroke Res; 2017 Dec; 8(6):549-559. PubMed ID: 28580536
[TBL] [Abstract][Full Text] [Related]
31. Endothelial LRP1 protects against neurodegeneration by blocking cyclophilin A.
Nikolakopoulou AM; Wang Y; Ma Q; Sagare AP; Montagne A; Huuskonen MT; Rege SV; Kisler K; Dai Z; Körbelin J; Herz J; Zhao Z; Zlokovic BV
J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33533918
[TBL] [Abstract][Full Text] [Related]
32. Normobaric hyperoxia slows blood-brain barrier damage and expands the therapeutic time window for tissue-type plasminogen activator treatment in cerebral ischemia.
Liang J; Qi Z; Liu W; Wang P; Shi W; Dong W; Ji X; Luo Y; Liu KJ
Stroke; 2015 May; 46(5):1344-1351. PubMed ID: 25804925
[TBL] [Abstract][Full Text] [Related]
33. The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells.
Yamada K; Hashimoto T; Yabuki C; Nagae Y; Tachikawa M; Strickland DK; Liu Q; Bu G; Basak JM; Holtzman DM; Ohtsuki S; Terasaki T; Iwatsubo T
J Biol Chem; 2008 Dec; 283(50):34554-62. PubMed ID: 18940800
[TBL] [Abstract][Full Text] [Related]
34. Recombinant tissue plasminogen activator induces blood-brain barrier breakdown by a matrix metalloproteinase-9-independent pathway after transient focal cerebral ischemia in mouse.
Copin JC; Bengualid DJ; Da Silva RF; Kargiotis O; Schaller K; Gasche Y
Eur J Neurosci; 2011 Oct; 34(7):1085-92. PubMed ID: 21895804
[TBL] [Abstract][Full Text] [Related]
35. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
Liu H; Wang Y; Xiao Y; Hua Z; Cheng J; Jia J
Transl Stroke Res; 2016 Jun; 7(3):209-19. PubMed ID: 27018013
[TBL] [Abstract][Full Text] [Related]
36. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
Hassanipour M; Zarisfi M; Ehsani V; Allahtavakoli M
Life Sci; 2020 Sep; 256():117450. PubMed ID: 32087233
[TBL] [Abstract][Full Text] [Related]
37. Tissue-Type Plasminogen Activator-A296-299 Prevents Impairment of Cerebral Autoregulation After Stroke Through Lipoprotein-Related Receptor-Dependent Increase in cAMP and p38.
Armstead WM; Riley J; Yarovoi S; Higazi AA; Cines DB
Stroke; 2016 Aug; 47(8):2096-102. PubMed ID: 27354223
[TBL] [Abstract][Full Text] [Related]
38. The choroid plexus: a door between the blood and the brain for tissue-type plasminogen activator.
Zuba V; Furon J; Bellemain-Sagnard M; Martinez de Lizarrondo S; Lebouvier L; Rubio M; Hommet Y; Gauberti M; Vivien D; Ali C
Fluids Barriers CNS; 2022 Oct; 19(1):80. PubMed ID: 36243724
[TBL] [Abstract][Full Text] [Related]
39. Isoflurane preconditioning inhibits the effects of tissue-type plasminogen activator on brain endothelial cell in an
Cheon SY; Kim SY; Kam EH; Lee JH; Kim JM; Kim EJ; Kim TW; Koo BN
Int J Med Sci; 2017; 14(5):425-433. PubMed ID: 28539818
[TBL] [Abstract][Full Text] [Related]
40. A multimolecular signaling complex including PrP
Mattei V; Manganelli V; Martellucci S; Capozzi A; Mantuano E; Longo A; Ferri A; Garofalo T; Sorice M; Misasi R
J Neurochem; 2020 Feb; 152(4):468-481. PubMed ID: 31602645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
